| ACTIVE PHARMACEUTICAL INGREDIENTS |
| |
|
|
|
|
Products |
|
DMF / COS |
| |
|
|
|
1. |
Itopride HCI |
GI Sedatives, Antispasmodics, Prokinetics
|
Open Part |
2. |
Proguanil HCI IP/BP |
|
Open Part |
3. |
Sibutramine HCI IP/BP |
Appetite, Suppressants, Anti
Obesity Drugs
|
Open Part |
4. |
Nateglinide |
Oral Anti Diabetics & Related Drugs
|
CTD (Internal Specification) |
5. |
Venlafaxine HCI |
Antidepressants |
CTD (Internal Specification) |
6. |
Amoxapine |
Antidepressants |
CTD (Internal Specification) |
7. |
Loxapine Succinate |
Antidepressants |
CTD (Internal Specification) |
8. |
Aripiprazole |
Antidepressants |
CTD (Internal Specification) |
9. |
Propofol |
|
Open Part |
10. |
Oxcarbazepine |
|
Open Part |
11. |
Carbamazepine |
Anticonvulsants |
Open Part |
12. |
Cilostazole |
Peripherals Vasco
Dialators |
Open Part |
13. |
Betahistine HCI |
Antimetics & Antinauseants |
Open Part |
14. |
Dopamine HCI |
Intropic Agents |
Open Part |
15. |
Diacerein |
Antirheumatoid |
CTD (Internal Specification) |
16. |
Nitazoxanide |
Antidiarrhoeals |
Open Part |
17. |
Domperidone |
Hyperacidity,
Reflux & Antiemetics |
Open Part |
18. |
Pregabalin |
Neuropathic Pain |
Open Part |
19. |
Ranolazine |
Cardio Vascular |
Open Part |
20. |
Voglibose |
Anti Diabetics |
Open Part |
21. |
Rimonabant |
Anti Obesity |
Open Part |
22. |
Sucralfate USP |
Anti Acid |
Open Part |
| * Patent
Infringement is the responsibility of the buyers & the products are not offered where the valid patents is exits. |
